Lorenz Muller
Corporate Officer/Principal at MILESTONE PHARMACEUTICALS INC.
Net worth: 210 750 $ as of 2024-04-29
Profile
Lorenz Muller is currently the Chief Commercial Officer at Milestone Pharmaceuticals, Inc. He previously worked as the Executive Director-Thrombosis at Daiichi Sankyo, Inc. from 2008 to 2015, Vice President-Marketing & Healthcare Outcomes at CV Therapeutics, Inc. from 2001 to 2011, and Vice President-Marketing at EXACT Sciences Corp.
from 2016 to 2017.
Mr. Muller received his undergraduate and graduate degrees from Massachusetts Institute of Technology and his MBA from Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-04-26 | 133,386 ( 0.25% ) | 210 750 $ | 2024-04-29 |
Lorenz Muller active positions
| Companies | Position | Start |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Corporate Officer/Principal | 2017-09-30 |
Former positions of Lorenz Muller
| Companies | Position | End |
|---|---|---|
| EXACT SCIENCES CORPORATION | Sales & Marketing | 2017-06-30 |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Corporate Officer/Principal | 2015-11-30 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Sales & Marketing | 2011-05-01 |
Training of Lorenz Muller
| Massachusetts Institute of Technology | Graduate Degree |
| Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| EXACT SCIENCES CORPORATION | Health Technology |
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| Private companies | 2 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |
- Stock Market
- Insiders
- Lorenz Muller
